Hoping to see the Q2 Report this week, if history is a guide. I don't expect much in the way of business results yet, but hopefully they will provide some color on enrollment/progress in the FDA trial. The start of Q4 is only about 6 weeks away now, so I would also expect to see some progress with the SEC later in the summer. If a return to trading can coincide with some positive preliminary results from the clinical trial, things will begin to get interesting again.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.